World Markets Generics & Biosimilars

Service Features

• Delivered via the Web to your desktop, Same-Day Analysis provides timely, consistent, and ongoing interpretations of regional, national, and global developments affecting the generics industry. The analyses are written on a daily basis by a team of regional and industry experts who monitor more than 60 pharmaceutical markets. Topics covered include:
  • Financial results of leading industry players
  • Merger and acquisition (M&A) activity
  • Marketing/R&D partnerships
  • Generic drug filings and approvals
  • Pipeline developments
  • Drug launch and pricing announcements
  • Patent challenges and disputes
  • Regulatory changes affecting the generic sector
  • Pricing and reimbursement policy revisions
  • Generic market size and growth trends
  • Efforts to promote the use of generics
  • The evolution of generics and biosimilars approval regulations
  
  
• Monthly Special Reports provide in-depth analysis on a wide range of topics affecting generics and biosimilars at regional, global, therapeutic group, and corporate levels.
  
  
• Country Reports provide a structured and consistent analysis of the generics sector in 17 markets, including BRIC and fast-growing CEE markets. These continually updated reports provide in-depth analysis of the regulatory and pricing and reimbursement environment for generics, competitive challenges, and barriers to market entry, along with the informal arrangements that could impact generics pricing and launch strategies in each market.
  
  
• Company Profiles of the top generics industry players provide an overview of company operations and strategy, including product portfolio and pipeline developments, financial performance, and M&A activity.
  
  
• The searchable Generics Pricing and Reimbursement Database provides regularly updated factory and retail prices and reimbursement level for every single dosage form of generics approved in the top-five EU markets and the United States since 2003.
  
  
• The Litigation Highlights Database tracks and analyzes patent litigation in the United States affecting the top-50 pharmaceutical products.
  
  
• The Biosimilars Market Watch provides in-depth review of regulatory changes relating to abbreviated approval of biosimilars through a separate set of country reports, while databases track biosimilars market opportunities and the companies involved in biosimilars development.